Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · Real-Time Price · USD

10.36

+6.07 (141.49%)

At close: Oct 8, 2025, 4:00 PM EDT

10.50

+0.14 (1.35%)

After-hours: Oct 8, 2025, 7:59 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Cell-based Therapeutics	2.54M	Log In	Log In	Log In	Log In	Upgrade
Cell-based Therapeutics Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	2.54M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade